ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Judge Rules FDA Modernization Act Violates First Amendment Over Publications Policy

August 6, 1999

In Brief: Stephen Schimpff Accepts New Position Of Executive Vice President Of Univ. Of Maryland Medical System

October 4, 1985

DRCCA To Get Name Change, Three Major Program Areas

August 27, 1982

Wyngaarden Law With Appointment Report; DeVita Tells Congress “We’re Addressing The Issue Internally”

March 20, 1987

NCCS Appointment Marks Transition To New Structure.

March 17, 2000

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010